Home/Investors/GIC

GIC

Biotech Investor · 3 portfolio companies

Portfolio

3

Combined Value

$164.9B

Focus Areas

7

Top Stage

commercial

Investment Focus

Oncology Immunology Neurology Cardiovascular Infectious Disease Rare Diseases Vaccines

Portfolio Companies

Company	Stage	Valuation	Focus
PPD	N/A (Service Provider)	$164.9B	Oncology, Immunology
CStone Pharmaceuticals	commercial	—	Oncology, Immunology
Solugen	commercial	—	—

Frequent Co-Investors

Founders Fund1 shared Hillhouse Capital1 shared Boyu Capital1 shared Thermo Fisher Scientific1 shared The Carlyle Group1 shared Hellman & Friedman1 shared Abu Dhabi Investment Authority1 shared Lilly Asia Ventures1 shared